Alamar Biosciences (ALMR): Down From the Peak, Still Above the Offering
Alamar’s proteomics growth remains strong, but a sharp pullback has reset expectations. Investors now face a premium valuation, continued losses...
23 Views
Primer: Alamar Biosciences (ALMR US) - Aug 2026
Proprietary Technology Driving Strong Growth: Alamar Biosciences is a commercial-stage proteomics company experiencing rapid revenue growth,...
107 Views
Alamar Biosciences (ALMR): Scarcity and Growth Power Strong First-Day Rally for Proteomics Platform
​Alamar Biosciences IPO priced at $17.00, opened up 32.9% due to strong institutional demand and rapid revenue growth in proteomics platform.
239 Views
Alamar Biosciences (ALMR): Bio-Platform Company Scales, Draws Heavy IPO Interest
​Strong commercialization and institutional demand drive revenue growth and IPO success for company backed by top-tier investors in a large market...
705 Views
IPO Rating: Alamar Bioscienes, Inc.
✅ IPO PROPHET RATING: 7.78/10 🏦 Deal Quality & Underwriters: 8.4/10 Alamar Biosciences is coming to market offering approximately 9.4 million...
107 Views